ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/18 | 2,132 | 2,148 | 2,114 | 2,147 | +31 | +1.5% | 61,200 |
| 2022/10/17 | 2,120 | 2,129 | 2,107 | 2,116 | -16 | -0.8% | 60,700 |
| 2022/10/14 | 2,133 | 2,151 | 2,109 | 2,132 | +26 | +1.2% | 86,900 |
| 2022/10/13 | 2,100 | 2,118 | 2,091 | 2,106 | -8 | -0.4% | 61,900 |
| 2022/10/12 | 2,093 | 2,116 | 2,085 | 2,114 | +21 | +1% | 93,000 |
| 2022/10/11 | 2,081 | 2,125 | 2,081 | 2,093 | -18 | -0.9% | 75,600 |
| 2022/10/07 | 2,109 | 2,130 | 2,109 | 2,111 | -24 | -1.1% | 55,300 |
| 2022/10/06 | 2,124 | 2,153 | 2,119 | 2,135 | +4 | +0.2% | 71,900 |
| 2022/10/05 | 2,145 | 2,151 | 2,125 | 2,131 | +9 | +0.4% | 67,900 |
| 2022/10/04 | 2,083 | 2,122 | 2,079 | 2,122 | +53 | +2.6% | 81,900 |
| 2022/10/03 | 2,063 | 2,073 | 2,046 | 2,069 | -3 | -0.1% | 53,900 |
| 2022/09/30 | 2,068 | 2,097 | 2,059 | 2,072 | +8 | +0.4% | 106,400 |
| 2022/09/29 | 2,029 | 2,069 | 2,014 | 2,064 | +37 | +1.8% | 115,000 |
| 2022/09/28 | 2,005 | 2,035 | 2,002 | 2,027 | +19 | +0.9% | 140,900 |
| 2022/09/27 | 1,999 | 2,028 | 1,999 | 2,008 | +13 | +0.7% | 108,600 |
| 2022/09/26 | 1,984 | 2,003 | 1,984 | 1,995 | -8 | -0.4% | 91,300 |
| 2022/09/22 | 2,006 | 2,012 | 1,990 | 2,003 | -30 | -1.5% | 118,400 |
| 2022/09/21 | 2,020 | 2,044 | 2,020 | 2,033 | -7 | -0.3% | 54,300 |
| 2022/09/20 | 2,043 | 2,051 | 2,031 | 2,040 | +7 | +0.3% | 45,800 |
| 2022/09/16 | 2,027 | 2,052 | 2,027 | 2,033 | -5 | -0.2% | 68,100 |
| 2022/09/15 | 2,072 | 2,072 | 2,032 | 2,038 | -23 | -1.1% | 54,000 |
| 2022/09/14 | 2,049 | 2,069 | 2,046 | 2,061 | -31 | -1.5% | 60,400 |
| 2022/09/13 | 2,095 | 2,095 | 2,082 | 2,092 | -10 | -0.5% | 37,300 |
| 2022/09/12 | 2,110 | 2,110 | 2,081 | 2,102 | -6 | -0.3% | 49,800 |
| 2022/09/09 | 2,085 | 2,117 | 2,085 | 2,108 | +24 | +1.2% | 104,200 |
| 2022/09/08 | 2,061 | 2,093 | 2,054 | 2,084 | +51 | +2.5% | 86,800 |
| 2022/09/07 | 2,025 | 2,040 | 2,016 | 2,033 | -7 | -0.3% | 61,900 |
| 2022/09/06 | 2,060 | 2,074 | 2,032 | 2,040 | -15 | -0.7% | 72,100 |
| 2022/09/05 | 2,069 | 2,070 | 2,044 | 2,055 | -34 | -1.6% | 69,200 |
| 2022/09/02 | 2,083 | 2,089 | 2,076 | 2,089 | +12 | +0.6% | 71,100 |
| 2022/09/01 | 2,064 | 2,093 | 2,064 | 2,077 | -6 | -0.3% | 68,700 |
| 2022/08/31 | 2,080 | 2,095 | 2,077 | 2,083 | -31 | -1.5% | 67,900 |
| 2022/08/30 | 2,098 | 2,116 | 2,093 | 2,114 | +16 | +0.8% | 41,500 |
| 2022/08/29 | 2,088 | 2,105 | 2,081 | 2,098 | -35 | -1.6% | 60,500 |
| 2022/08/26 | 2,136 | 2,150 | 2,130 | 2,133 | -3 | -0.1% | 36,800 |
| 2022/08/25 | 2,147 | 2,153 | 2,136 | 2,136 | -1 | ±0% | 33,300 |
| 2022/08/24 | 2,139 | 2,147 | 2,122 | 2,137 | -10 | -0.5% | 46,900 |
| 2022/08/23 | 2,144 | 2,162 | 2,129 | 2,147 | -19 | -0.9% | 37,700 |
| 2022/08/22 | 2,138 | 2,166 | 2,127 | 2,166 | +19 | +0.9% | 29,000 |
| 2022/08/19 | 2,152 | 2,160 | 2,140 | 2,147 | +5 | +0.2% | 33,300 |
| 2022/08/18 | 2,171 | 2,173 | 2,134 | 2,142 | -38 | -1.7% | 58,400 |
| 2022/08/17 | 2,199 | 2,199 | 2,163 | 2,180 | +4 | +0.2% | 49,600 |
| 2022/08/16 | 2,184 | 2,191 | 2,165 | 2,176 | -7 | -0.3% | 46,300 |
| 2022/08/15 | 2,180 | 2,185 | 2,156 | 2,183 | +36 | +1.7% | 64,600 |
| 2022/08/12 | 2,116 | 2,173 | 2,116 | 2,147 | +25 | +1.2% | 66,400 |
| 2022/08/10 | 2,113 | 2,138 | 2,089 | 2,122 | +34 | +1.6% | 85,200 |
| 2022/08/09 | 2,136 | 2,147 | 2,077 | 2,088 | -58 | -2.7% | 93,600 |
| 2022/08/08 | 2,157 | 2,181 | 2,118 | 2,146 | -2 | -0.1% | 64,600 |
| 2022/08/05 | 2,230 | 2,230 | 2,145 | 2,148 | +68 | +3.3% | 166,900 |
| 2022/08/04 | 2,087 | 2,089 | 2,055 | 2,080 | +9 | +0.4% | 64,400 |
701～
750
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
